Nikko Asset Management Americas’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-2,000
Closed -$420K 334
2016
Q4
$420K Sell
2,000
-100
-5% -$20.7K 0.03% 177
2016
Q3
$484K Sell
2,100
-900
-30% -$220K 0.04% 153
2016
Q2
$692K Hold
3,000
0.07% 121
2016
Q1
$825K Buy
+3,000
New +$859K 0.1% 101
2015
Q4
Sell
-2,100
Closed -$529K 195
2015
Q3
$529K Hold
2,100
0.05% 122
2015
Q2
$628K Hold
2,100
0.04% 129
2015
Q1
$640K Buy
2,100
+700
+50% +$200K 0.05% 132
2014
Q4
$363K Buy
+1,400
New +$350K 0.03% 172

Other funds holding AGN

Nikko Asset Management Americas's AGN Position: Q1 2017 in Review

Nikko Asset Management Americas sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 2,000 shares — an estimated $420K sold.

Nikko Asset Management Americas first reported a position in AGN in Q4 2014 and held it in 8 quarters. The position peaked at $825K in Q1 2016. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

  • Nikko Asset Management Americas reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
  • Nikko Asset Management Americas sold 2,000 Allergan plc shares in Q1 2017, an estimated $420K.
  • Nikko Asset Management Americas first reported a position in Allergan plc in Q4 2014 and held it in 8 quarters.
  • Nikko Asset Management Americas's Allergan plc position peaked at $825K in Q1 2016.
  • 1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Nikko Asset Management Americas's 13F filing for Q1 2017, filed 26 Apr 2017.